AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 223 filers reported holding AMICUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $163,895 | +218.2% | 13,049 | +180.9% | 0.05% | +182.4% |
| Q1 2023 | $51,513 | -74.0% | 4,645 | -71.4% | 0.02% | -74.2% |
| Q4 2022 | $198,474 | -45.6% | 16,255 | -57.9% | 0.07% | -63.9% |
| Q1 2022 | $365,000 | -14.5% | 38,608 | +4.4% | 0.18% | -8.0% |
| Q4 2021 | $427,000 | +44.3% | 36,986 | +19.3% | 0.20% | +4.7% |
| Q3 2021 | $296,000 | -6.0% | 30,993 | -5.2% | 0.19% | -4.0% |
| Q2 2021 | $315,000 | +986.2% | 32,676 | +1002.1% | 0.20% | +312.5% |
| Q1 2021 | $29,000 | – | 2,965 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |